Management of Allergic Reactions
Epinephrine is the first-line treatment for anaphylaxis and should be administered immediately upon recognition of symptoms, with no absolute contraindications to its use in this life-threatening condition. 1, 2
Classification and Initial Management
Mild to Moderate Allergic Reactions
- Symptoms: Flushing, urticaria, isolated mild angioedema, pruritus
- Treatment:
Severe Allergic Reactions/Anaphylaxis
- Symptoms: Respiratory distress, hypotension, widespread urticaria, significant angioedema, laryngospasm, bronchospasm
- Treatment:
- First-line: Epinephrine IM 1, 2, 4
- Weight 10-25 kg: 0.15 mg epinephrine autoinjector in anterior-lateral thigh
- Weight >25 kg: 0.3 mg epinephrine autoinjector in anterior-lateral thigh
- Alternative dosing: Epinephrine (1:1000 solution) 0.01 mg/kg IM, maximum 0.5 mg
- May need to repeat doses every 5-15 minutes if symptoms persist
- First-line: Epinephrine IM 1, 2, 4
Adjunctive Treatments (Only After Epinephrine for Anaphylaxis)
Bronchodilators (for bronchospasm)
- Albuterol via MDI or nebulizer 1
Antihistamines (not a substitute for epinephrine in anaphylaxis)
Corticosteroids (may help prevent biphasic reactions, though evidence is limited)
- Prednisone daily for 2-3 days 1
Supportive care
- Supplemental oxygen if needed
- IV fluids for hypotension
- Place patient in recumbent position with lower extremities elevated if tolerated 1
Post-Treatment Management
Observation Period
- All patients who receive epinephrine should be transferred to an emergency facility 1
- Observe for 4-6 hours after successful treatment 1
- Longer observation or hospital admission for severe or refractory symptoms 1
- Monitor for biphasic reactions (can occur up to 72 hours later) 1
Discharge Plan After Anaphylaxis
- Provide emergency action plan 1, 5
- Prescribe epinephrine autoinjector (2 doses) 1, 4, 6
- Continue medications for 2-3 days 1
- H1 antihistamine (consider switching to non-sedating option) 3
- H2 antihistamine
- Corticosteroid
- Schedule follow-up with primary care provider and consider referral to allergist/immunologist 1
- Recommend medical identification jewelry for patients at risk 1
High-Risk Patients
Special attention should be given to patients with:
- Previous history of anaphylaxis
- Asthma (especially poorly controlled)
- Known allergy to peanuts, tree nuts, fish, or shellfish
- Mast cell disorders
- Cardiovascular disease 1, 7
Common Pitfalls to Avoid
- Delaying epinephrine administration - this is associated with increased mortality 1, 4, 8
- Using antihistamines alone for anaphylaxis - they are not sufficient and may delay proper treatment 1, 3
- Failing to prescribe autoinjectors - patients at risk should carry two doses at all times 1, 6
- Inadequate observation time - patients should be monitored for potential biphasic reactions 1
- Insufficient patient education - patients need clear instructions on allergen avoidance and when/how to use epinephrine 1, 5
Remember that there are no absolute contraindications to epinephrine in anaphylaxis, as the risk of death from untreated anaphylaxis outweighs potential adverse effects of epinephrine 1.